According to Global Cancer Statistics in 2021 gastric cancer (GC, upper third and distal gastric cancer combined) remains an important cancer worldwide and is responsible for over one million new ...

Conversion surgery, particularly one-anastomosis gastric bypass, delivers greater and more durable weight loss than medication therapy in patients with recurrent weight gain after sleeve gastrectomy. ...

Effect of nivolumab combined with definitive chemoradiotherapy on response rate for esophageal cancer: An immune active intrinsic subtype could be its biomarker—The NOBEL trial. This is an ASCO ...

The most accepted procedures as conversion for poor weight changes after sleeve gastrectomy (SG), are malabsorptive surgeries. This study was designed to evaluate the 5-year outcomes of One ...

Phase II study of trastuzumab with irinotecan in HER2-positive metastatic or advanced gastric cancer patients previously treated with trastuzumab and failed: HGCSG 1201/OGSG1205. This is an ASCO ...

Conversion surgery after active surveillance for low-risk papillary thyroid carcinoma (PTC) led to no clinically meaningful differences in outcomes as compared with immediate surgery, according to a ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Results showed several surgical and patient factors were significantly associated with conversion from ...